Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Sigma-Tau IMS Company Profile Highlights the Company's Strengths / Weaknesses and Its Potential for Future Growth
August 31st, 2007
Research and Markets has announced the addition of "Sigma-Tau IMS Company Profile" to their offering. IMS Health's Company Profiles give you the authoritative insight into a company at a strategic and local level. Each individual IMS Company Profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the relative strengths and weaknesses of a company's business strategy. - Critical analyses provided by an in-house expert team - 90+ full in-depth company profiles covering all major pharmaceutical...
Source: Drug Week (2007-08-31)
|
